Na+/H+ Exchanger 1 is regulated via its lipid-interacting domain, which functions as a molecular switch: A pharmacological approach using indolocarbazole compounds

Molecular Pharmacology

Volumn 85, Issue 1, 2014, Pages 18-28

  Shimada Shimizu, Naoko ^a   Hisamitsu, Takashi ^a   Nakamura, Tomoe Y ^a   Hirayama, Noriaki ^b   Wakabayashi, Shigeo ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; BISINDOLYLMALEIMIDE; CARBAZOLE DERIVATIVE; INDOLOCARBAZOLE DERIVATIVE; OKADAIC ACID; PHORBOL ESTER; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; PROTEIN KINASE C; SODIUM PROTON EXCHANGE PROTEIN 1; STAUROSPORINE; TRINITROPHENYL; UNCLASSIFIED DRUG;

ARTICLE; BINDING COMPETITION; CONTROLLED STUDY; HYPEROSMOTIC STRESS; LIPID INTERACTING DOMAIN; MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN INDUCTION; REGULATORY MECHANISM;

EID: 84890703276     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.113.089268     Document Type: Article

References (32)

1. Abu Jawdeh BG, Khan S, Deschênes I, Hoshi M, Goel M, Lock JT, Shinlapawittayatorn K, Babcock G, Lakhe-Reddy S, and DeCaro G et al. (2011) Phosphoinositide binding differentially regulates NHE1 Na1/H1 exchanger-dependent proximal tubule cell survival. J Biol Chem 286:42435-42445.
2. Aharonovitz O, Zaun HC, Balla T, York JD, Orlowski J, and Grinstein S (2000) Intracellular pH regulation by Na(1)/H(1) exchange requires phosphatidylinositol 4,5-bisphosphate. J Cell Biol 150:213-224.
3. Baartscheer A, Hardziyenka M, Schumacher CA, Belterman CN, van Borren MM, Verkerk AO, Coronel R, and Fiolet JW (2008) Chronic inhibition of the Na1/H1-exchanger causes regression of hypertrophy, heart failure, and ionic and electrophysiological remodelling. Br J Pharmacol 154:1266-1275.
4. Cardone RA, Casavola V, and Reshkin SJ (2005) The role of disturbed pH dynamics and the Na1/H1 exchanger in metastasis. Nat Rev Cancer 5:786-795.
5. Cassel D, Katz M, and Rotman M (1986) Depletion of cellular ATP inhibits Na1/H1 antiport in cultured human cells. Modulation of the regulatory effect of intracellular protons on the antiporter activity. J Biol Chem 261:5460-5466.
6. Fuster D, Moe OW, and Hilgemann DW (2004) Lipid-and mechanosensitivities of sodium/hydrogen exchangers analyzed by electrical methods. Proc Natl Acad Sci USA 101:10482-10487.
7. Guarnieri MT, Blagg BS, and Zhao R (2011) A high-throughput TNP-ATP displacement assay for screening inhibitors of ATP-binding in bacterial histidine kinases. Assay Drug Dev Technol 9:174-183.
8. Heikkilä J, Jalava A, and Eriksson K (1993) The selective protein kinase C inhibitor GF 109203X inhibits phorbol ester-induced morphological and functional differentiation of SH-SY5Y human neuroblastoma cells. Biochem Biophys Res Commun 197:1185-1193.
9. Horio K, Muta H, Goto J, and Hirayama N (2007) A simple method to improve the odds in finding 'lead-like' compounds from chemical libraries. Chem Pharm Bull (Tokyo) 55:980-984.
10. Huber JD, Bentzien J, Boyer SJ, Burke J, De Lombaert S, Eickmeier C, Guo X, Haist JV, Hickey ER, and Kaplita P et al. (2012) Identification of a potent sodium hydrogen exchanger isoform 1 (NHE1) inhibitor with a suitable profile for chronic dosing and demonstrated cardioprotective effects in a preclinical model of myocardial infarction in the rat. J Med Chem 55:7114-7140.
11. Karmazyn M (2013). NHE-1: Still a viable therapeutic target. J Mol Cell Cardiol 61: 77-82.
12. Karmazyn M, Kili-c A, and Javadov S (2008) The role of NHE-1 in myocardial hypertrophy and remodelling. J Mol Cell Cardiol 44:647-653.
13. L'Allemain G, Paris S, and Pouysségur J (1984) Growth factor action and intracellular pH regulation in fibroblasts: Evidence for a major role of the Na1/H1 antiport. J Biol Chem 259:5809-5815.
14. Little PJ, Weissberg PL, Cragoe EJ, Jr, and Bobik A (1988) Dependence of Na1/H1 antiport activation in cultured rat aortic smooth muscle on calmodulin, calcium, and ATP. Evidence for the involvement of calmodulin-dependent kinases. J Biol Chem 263:16780-16786.
15. Nakamura TY, Iwata Y, Arai Y, Komamura K, and Wakabayashi S (2008) Activation of Na1/H1 exchanger 1 is sufficient to generate Ca21 signals that induce cardiac hypertrophy and heart failure. Circ Res 103:891-899.
16. Nakano H and Omura S (2009) Chemical biology of natural indolocarbazole products: 30 years since the discovery of staurosporine. J Antibiot (Tokyo) 62:17-26.
17. Ohmori S, Sakai N, Shirai Y, Yamamoto H, Miyamoto E, Shimizu N, and Saito N (2000) Importance of protein kinase C targeting for the phosphorylation of its substrate, myristoylated alanine-rich C-kinase substrate. J Biol Chem 275: 26449-26457.
18. Orlowski J and Grinstein S (2004) Diversity of the mammalian sodium/proton exchanger SLC9 gene family. Pflugers Arch 447:549-565.
19. Pouysségur J, Sardet C, Franchi A, L'Allemain G, and Paris S (1984) A specific mutation abolishing Na1/H1 antiport activity in hamster fibroblasts precludes growth at neutral and acidic pH. Proc Natl Acad Sci USA 81:4833-4837.
20. Sánchez C, Méndez C, and Salas JA (2006) Indolocarbazole natural products: Occurrence, biosynthesis, and biological activity. Nat Prod Rep 23:1007-1045.
21. Sardet C, Fafournoux P, and Pouysségur J (1991) Alpha-thrombin, epidermal growth factor, and okadaic acid activate the Na1/H1 exchanger, NHE-1, by phosphorylating a set of common sites. J Biol Chem 266:19166-19171.
22. Shimada-Shimizu N, Hisamitsu T, Nakamura TY, and Wakabayashi S (2013) Evidence that Na1/H1 exchanger 1 is an ATP-binding protein. FEBS J 280: 1430-1442.
23. Taylor CW (2002) Controlling calcium entry. Cell 111:767-769.
24. Toledo LM and Lydon NB (1997) Structures of staurosporine bound to CDK2 and cAPK - new tools for structure-based design of protein kinase inhibitors. Structure 5:1551-1556.
25. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E, and Loriolle F et al. (1991) The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 266: 15771-15781.
26. Wakabayashi S, Bertrand B, Ikeda T, Pouysségur J, and Shigekawa M (1994a) Mutation of calmodulin-binding site renders the Na1/H1 exchanger (NHE1) highly H(1)-sensitive and Ca21 regulation-defective. J Biol Chem 269:13710-13715.
27. Wakabayashi S, Bertrand B, Shigekawa M, Fafournoux P, and Pouysségur J (1994b) Growth factor activation and "H(1)- sensing" of the Na1/H1 exchanger isoform 1 (NHE1): Evidence for an additional mechanism not requiring direct phosphorylation. J Biol Chem 269:5583-5588.
28. Wakabayashi S, Hisamitsu T, and Nakamura TY (2013) Regulation of the cardiac Na/H exchanger in health and disease. J Mol Cell Cardiol 61:68-76.
29. Wakabayashi S, Nakamura TY, Kobayashi S, and Hisamitsu T (2010) Novel phorbol ester-binding motif mediates hormonal activation of Na1/H1 exchanger. J Biol Chem 285:26652-26661.
30. Wakabayashi S, Pang T, Su X, and ShigekawaM (2000) A novel topology model of the human Na(1)/H(1) exchanger isoform 1. J Biol Chem 275:7942-7949.
31. Wakabayashi S, Shigekawa M, and Pouyssegur J (1997) Molecular physiology of vertebrate Na1/H1 exchangers. Physiol Rev 77:51-74.
32. Walker EH, Pacold ME, Perisic O, Stephens L, Hawkins PT, Wymann MP, and Williams RL (2000) Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Mol Cell 6:909-919.